TERAZOSIN Drug Record

  • TERAZOSIN CHEMBL611 FDA ApprovedAntineoplastic

    Alternate Names:

    Terazosin
    Hytrin
    DB01162
    1-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)-4-[[(2RS)-2,3,4,5-TETRAHYDROFURAN-2-YL]CARBONYL]PIPERAZINE
    METHANONE, [4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL](TETRAHYDRO-2-FURANYL)-
    6,7-DIMETHOXY-2-[4-(TETRAHYDRO-2-FURANYLCARBONYL)-1-PIPERAZINYL]-4-QUINAZOLINAMINE #
    6,7-DIMETHOXY-2-[4-(OXOLANE-2-CARBONYL)PIPERAZIN-1-YL]-3,4-DIHYDROQUINAZOLIN-4-IMINE
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-TETRAHYDROFUROYL)-PIPERAZINE
    [4-(4-AMINO-6,7-DIMETHOXY-QUINAZOLIN-2-YL)PIPERAZIN-1-YL]-TETRAHYDROFURAN-2-YL-METHANONE
    6,7-DIMETHOXY-2-[4-(OXOLANE-2-CARBONYL)PIPERAZIN-1-YL]QUINAZOLIN-4-AMINE
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(2-TETRAHYDROFUROYL)PIPERAZINE
    FT-0630739
    KB-147102
    H963
    AN-38972
    NCGC00016026-11
    NCGC00016026-05
    NCGC00016026-04
    1- 4-[ CARBONYL]PIPERAZINEHYDROCHLORIDE
    VA11839
    NC00689
    MCULE-4030111564
    CS-2429
    CCG-205212
    AKOS005266642
    DAP000371
    BDBM50033111
    BBL010743
    4097AH
    HY-B0371
    HMS3371E20
    HMS3369P14
    HMS3259F04
    HMS2232N21
    MOLPORT-001-684-489
    MET029
    GTPL7302
    MLS006011889
    REGID_FOR_CID_5401
    SCHEMBL6528
    CID5401
    HYTRINREG
    TERAZOSABB
    6,7-BIS(METHYLOXY)-2-[4-(TETRAHYDROFURAN-2-YLCARBONYL)PIPERAZIN-1-YL]QUINAZOLIN-4-AMINE
    [4-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)PIPERAZIN-1-YL]-(OXOLAN-2-YL)METHANONE
    [4-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)PIPERAZIN-1-YL](TETRAHYDROFURAN-2-YL)METHANONE
    MLS001305722
    BRD-A22256192-003-03-7
    L000692
    A-45975
    PIPERAZINE, 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-((TETRAHYDRO-2-FURANYL)CARBONYL)-
    6,7-DIMETHOXY-2-[4-(TETRAHYDROFURAN-2-YLCARBONYL)PIPERAZIN-1-YL]QUINAZOLIN-4-AMINE
    D08569
    C07127
    70024-40-7 (MONO-HYDROCHLORIDE, DIHYDRATE)
    1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(TETRAHYDRO-2-FUROYL)PIPERAZINE
    LS-110234
    SMR000058309
    CPD000058309
    AC-11120
    NCGC00025191-03
    NCGC00016026-08
    TERAZOSIN HCL
    STK567029
    A 45975
    63074-08-8 (HYDROCHLORIDE)
    VCKUSRYTPJJLNI-UHFFFAOYSA-N
    STOCK4S-28262
    BPBIO1_000840
    MLS001201836
    MLS000069703
    UNII-8L5014XET7
    SPBIO_002701
    BSPBIO_000762
    LOPAC0_001138
    AC1L1K9W
    PRESTWICK3_000751
    PRESTWICK2_000751
    PRESTWICK1_000751
    PRESTWICK0_000751
    C19H25N5O4
    CHEBI:9445
    VICARD
    ITRIN
    HYTRINEX
    TERAZOSIN (INN)
    TERAZOSABB (TN)
    TRAZOSIN HCL
    TERAZOSIN [INN:BAN]
    HYTRACIN
    TERAZOSINA [INN-SPANISH]
    TERAZOSINUM [INN-LATIN]
    TERAZOSINE [INN-FRENCH]
    ZAYASEL
    63590-64-7
    VASOMET
    TERAZOSINUM
    TERAZOSINA
    BLAVIN
    FOSFOMIC
    FLUMARC
    TERAZOSINE
    5401
    SAM002589982
    HMS2090P21
    9337
    178103875
    7302
    318164856
    COMPOUND 3 [PMID: 27347366]

    Drug Info:

    FDA Approval 1987
    Drug Class small molecule
    Drug Indications antihypertensive agents
    Drug Indications Antineoplastic Agents
    Drug Class antineoplastic agents
    Year of Approval 1987
    Drug Class antihypertensive agents
    (2 More Sources)

    Publications:

  • TERAZOSIN   ADRA1D

    Interaction Types:
    antagonist

    Interaction Info:
    Trial Name -
    Novel drug target Established target

    Publications:

  • TERAZOSIN   ADRA1B

    Interaction Types:
    antagonist

    Interaction Info:
    Trial Name -
    Novel drug target Established target
    Specific Action of the Ligand Antagonist

    Publications:

  • TERAZOSIN   ADRA1A

    Interaction Types:
    antagonist

    Interaction Info:
    Trial Name -
    Novel drug target Established target
    Specific Action of the Ligand Antagonist

    Publications:

  • TERAZOSIN   BACE2

    Interaction Types:
    inhibitor

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? True

    Publications:

  • TEND: TERAZOSIN

    • Version: 01-August-2011

    Alternate Names:
    TERAZOSIN Primary Drug Name

    Drug Info:
    Drug Class antihypertensive agents
    Year of Approval 1987
    Drug Class antineoplastic agents

    Publications:

  • TdgClinicalTrial: TERAZOSIN

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications Antineoplastic Agents
    Drug Indications antihypertensive agents
    Drug Class small molecule

    Publications:

  • PubChem: TERAZOSIN

    • Version: 09-Feb-2016

    Alternate Names:
    HMS2090P21 Drug Synonym
    SAM002589982 Drug Synonym
    TERAZOSIN pubchem_primary_name

    Drug Info:

    Publications:

  • TTD: DAP000371

    • Version: 4.3.02 (25-August-2011)

    Alternate Names:
    TERAZOSINUM [INN-LATIN] Drug Synonym
    CHEBI:9445 Drug Synonym
    63074-08-8 (HYDROCHLORIDE) Drug Synonym

    Drug Info:

    Publications:

  • GuideToPharmacologyInteractions: 7302

    • Version: 27-September-2017

    Alternate Names:
    TERAZOSIN GuideToPharmacology Ligand Name
    178103875 PubChem Drug SID

    Drug Info:

    Publications:

  • GuideToPharmacologyInteractions: 9337

    • Version: 27-September-2017

    Alternate Names:
    COMPOUND 3 [PMID: 27347366] GuideToPharmacology Ligand Name
    318164856 PubChem Drug SID

    Drug Info:

    Publications: